Freedom of Information responses from the MHRA - week commencing 15 November 2021

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Freedom of Information request on MHRA PV Inspection reports conducted between August 2019 and January 2021

HTML

Freedom of Information request on the 486 Yellow Card adverse allergic reactions to the Pfizer vaccine, how many of these individuals had a history of allergic response to PEG, and how many had a history of a nut allergy (FOI 21/1212)

HTML

Freedom of Information request on a list of the quantitative scientific analyses that have been conducted to date that utilise data collected in the Yellow Card database of COVID-19 vaccine adverse events.(FOI 21/1102)

HTML

Freedom of Information request on report from: SMITHKLINE BEECHAM LIMITED INSP GMP 10592/1524-0020. ( FOI 21/1108)

HTML

Freedom of Information request on the Novavax and Valneva vaccines, which are not currently authorised for use (FOI 21/1201)

HTML

Freedom of Information request on timelines for the authorisation of Kaftrio in 6-11 year olds (FOI 21/1148)

HTML

Freedom of Information request on a report from the beginning of the vaccine program in Gibraltar to the 13.10.21 (FOI 21-1224)

HTML

Freedom of Information request on the number of adverse events reported through Yellow Card scheme for the Isle of Man that have been reported for all COVID-19 vaccines (FOI 21/1152)

HTML

Freedom of Information request on the amount of benzyl benzoatein Testosterone Enantate 250 mg/ ml Solution for Injection (PL 16853/0116 / 0015)- (FOI 21-1206)

HTML

Freedom of Information request on the updated figures for adverse reactions for all brands of COVID-19 vaccines to date received from the Isle of Man, and updated Drug Analysis Print attachments for each vaccine (FOI 21/1208)

HTML

Freedom of Information request on the authorisation of Repevax ( FOI 21/1196)

HTML

Freedom of Information request on new MAA's on Lidocaine (FOI 21/1213)

HTML

PDF, 399 KB, 20 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 2.75 MB, 73 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 58.6 KB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 68.1 KB, 35 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 28.4 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 38.2 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 102 KB, 27 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 28.4 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 38.2 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 102 KB, 27 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

188体育